Nurx Stock

nurx.comHealthcareFounded: 2015Funding to Date: $90.87MM

Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Nurx, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Varsha Rao
Chief Executive Officer
Jonathan Czaja
Chief Operating Officer
Edvard Engesaeth MD
Innovation Officer and Co-Founder
Sheena Deol
Executive Assistant
Hans Gangeskar
Co-Founder & Board Member
Matthew Dzaman
Head, Engineering
Michael Hourie
Head of Finance
Ted Kraus
Advisor

Board Members

Chelsea Clinton Ph.D
Clinton Foundation
Hans Gangeskar
Noah Knauf
Kleiner Perkins
Regina Benjamin MD

Other companies like Nurx in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$263MM

News

Nurx expects to be profitable by early next year.
Efforts to get at-home test kits for the COVID-19 coronavirus are ramping up quickly, and two more health industry startups are bringing their own products to market, with both Carbon Health and Nurx starting to ship their own in-home sample collection kits. Both of these new offerings are the same…
Nurx, a health tech company that is providing convenient and affordable care for sensitive needs, announced it raised $52 million.